Ligand Pharmaceuticals Inc
LGND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000886163
In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 6 sales; 417 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Ligand Pharmaceuticals Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 197
- −6 vs. Q2 2023
- Shares held
- 15.6M
- +182.7K (+1.2%) vs. Q2 2023
- Total value
- $946.5M
- −$168.6M (−15.1%) vs. Q2 2023
- New holders
- 20
- 67 more added
- Sold out
- 26
- 77 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 417 | $7.15B |
| Q1 2026 | 359 | $4.15B |
| Q4 2025 | 351 | $3.89B |
| Q3 2025 | 314 | $3.63B |
| Q2 2025 | 271 | $2.18B |
| Q1 2025 | 262 | $1.97B |
| Q4 2024 | 259 | $1.96B |
| Q3 2024 | 243 | $1.81B |
| Q2 2024 | 235 | $1.45B |
| Q1 2024 | 222 | $1.21B |
| Q4 2023 | 211 | $1.15B |
| Q3 2023 | 197 | $946.5M |
| Q2 2023 | 204 | $1.12B |
| Q1 2023 | 213 | $1.10B |
| Q4 2022 | 198 | $983.5M |
| Q3 2022 | 205 | $1.28B |
| Q2 2022 | 198 | $1.33B |
| Q1 2022 | 207 | $1.76B |
| Q4 2021 | 221 | $2.51B |
| Q3 2021 | 208 | $2.29B |
| Q2 2021 | 212 | $2.09B |
| Q1 2021 | 228 | $2.35B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Ligand Pharmaceuticals Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Zacks Investment Management | 0 | $0 | 0.00% | −11,452−100.0% | Sold out |
| Oversea-Chinese Banking CORP Ltd | 0 | $0 | 0.00% | −8,771−100.0% | Sold out |
| Quantedge Capital Pte Ltd | 0 | $0 | 0.00% | −7,900−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −6,161−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −3,949−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −3,785−100.0% | Sold out |
| Mutual of America Capital Management LLC | 0 | $0 | 0.00% | −3,206−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −3,165−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −3,102−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,945−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −2,832−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −2,810−100.0% | Sold out |
| Pinebridge Investments, L.P. | 0 | $0 | 0.00% | −208−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −187−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Disciplined Investments, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |